Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.

about

Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment.

P2860

Q51712877-BABAEF32-AAB5-4A02-9ADB-9559416FE331

P2860

Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.

Item

http://www.wikidata.org/entity/Q51284596

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Enhanced external counterpulsa ...... 3 months following treatment.

@en

type

Item

label

Enhanced external counterpulsa ...... 3 months following treatment.

@en

prefLabel

Enhanced external counterpulsa ...... 3 months following treatment.

@en

P1476

Enhanced external counterpulsa ...... 3 months following treatment.

@en

P2093

Jeffrey S Martin

http://www.w3.org/2001/XMLSchema#string

Joseph C Avery

http://www.w3.org/2001/XMLSchema#string

Paloma D Sardina

http://www.w3.org/2001/XMLSchema#string

Randy W Braith

http://www.w3.org/2001/XMLSchema#string

P2860

Skeletal muscle nitric oxide signaling and exercise: a focus on glucose metabolism

Current views on type 2 diabetes.

Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology

Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study.

The many ways to regulate glucose transporter 4.

Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study

The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan

Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus.

Role of nitric oxide in skeletal muscle glucose uptake during exercise.

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus.

P2888

s00592-016-0866-9

P304

745-752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00592-016-0866-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27179825

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.

about

P2860

P2860

Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921